Candel Therapeutics, Inc. (CADL)

Candel Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	92.17	102.65	35.41	70.06	82.64	35.05
Cash & Short-Term Investments	92.17	102.65	35.41	70.06	82.64	35.05
Cash Growth	258.44%	189.88%	-49.45%	-15.23%	135.76%	-22.20%
Prepaid Expenses	0.98	1.15	1.38	1.89	2.3	0.09
Total Current Assets	93.15	103.8	36.8	71.95	84.95	35.15
Property, Plant & Equipment	2.43	2.73	4.02	5.48	3.84	2.79
Other Long-Term Assets	0.32	0.33	0.38	0.27	0.42	0.35
Total Assets	95.91	106.87	41.2	77.69	89.21	38.28
Accounts Payable	0.76	0.24	0.42	0.38	1.59	0.92
Accrued Expenses	2.41	4.72	3.96	4.72	3.44	3.14
Short-Term Debt	-	-	-	-	-	0.46
Current Portion of Long-Term Debt	9.17	9.9	8.89	-	-	-
Current Portion of Leases	0.58	0.57	0.51	0.46	-	-
Other Current Liabilities	7.15	22.11	0.4	0.05	0.33	0.19
Total Current Liabilities	20.07	37.53	14.18	5.62	5.36	4.71
Long-Term Debt	0.9	2.6	12.38	20.85	0.56	0.48
Long-Term Leases	0.26	0.41	0.97	1.49	-	-
Long-Term Unearned Revenue	-	-	-	0.14	-	0.13
Other Long-Term Liabilities	-	-	0.92	1.88	19.15	7.46
Total Liabilities	21.23	40.54	28.46	29.98	25.07	12.78
Common Stock	0.49	0.47	0.29	0.29	0.29	0.12
Additional Paid-In Capital	259.46	258.51	149.93	146.96	144.15	20.49
Retained Earnings	-184.83	-192.21	-137.03	-99.09	-80.3	-44.17
Treasury Stock	-0.45	-0.45	-0.45	-0.45	-	-
Total Common Equity	74.68	66.33	12.75	47.71	64.14	-23.56
Shareholders' Equity	74.68	66.33	12.75	47.71	64.14	25.5
Total Liabilities & Equity	95.91	106.87	41.2	77.69	89.21	38.28
Total Debt	10.91	13.47	22.76	22.8	0.56	0.95
Net Cash (Debt)	81.25	89.18	12.65	47.26	82.08	34.11
Net Cash Growth	1655.66%	604.95%	-73.23%	-42.43%	140.66%	-23.59%
Net Cash Per Share	2.20	2.82	0.44	1.64	4.35	2.94
Filing Date Shares Outstanding	50.1	47.24	29.35	28.92	28.69	11.64
Total Common Shares Outstanding	49.25	46.81	29.09	28.92	28.69	11.64
Working Capital	73.08	66.28	22.61	66.33	79.58	30.43
Book Value Per Share	1.52	1.42	0.44	1.65	2.24	-2.03
Tangible Book Value	74.68	66.33	12.75	47.71	64.14	-23.56
Tangible Book Value Per Share	1.52	1.42	0.44	1.65	2.24	-2.03
Machinery	2.18	2.16	2.19	2.5	1.19	1.4
Construction In Progress	-	-	-	-	-	1.22
Leasehold Improvements	3.11	3.11	3.11	3.06	2.99	0.31

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q